DLAT also played roles in other types of cancer, Chen et al. (2022) reported that upregulated DLAT enhance the malignancy of NSCLC cells, and positively correlated with tumor size and poor prognosis of NSCLC patients. The gene discussed is DLAT; the disease is cancer.